Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back

A. Avan, P. Pacetti, M. Reni, M. Milella, E. Vasile, A. Mambrini, V. Vaccaro, S. Caponi, S. Cereda, G.J. Peters, M. Cantore, E. Giovannetti

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1016-1022
JournalInternational journal of cancer
Issue number4
Publication statusPublished - 2013

Cite this